RecruitingNot ApplicableNCT06261736
The Effectiveness of Prophylactic Antibiotics for Urethral Bulking
Sponsor
Atlantic Health System
Enrollment
70 participants
Start Date
Oct 24, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to evaluate if prophylactic antibiotics in urethral bulking are effective in reducing postprocedural urinary tract infections.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria2
- Patients scheduled to undergo a urethral bulking procedure
- Age 18 ≥ over
Exclusion Criteria6
- History of recurrent urinary tract infections
- Known history of urinary retention
- Allergies or contraindications to multiple antibiotics
- Inability to tolerate oral antibiotics
- Concomitant surgical procedures at the time of urethral bulking
- Pregnant or breastfeeding
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERProphylactic antibiotics
These participants will be given a single dose of an oral antibiotic prior to the procedure.
OTHERNo antibiotics
These participants will not be given an antibiotic prior to the procedure.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06261736
Related Trials
Effect of Vulvar Re-Antisepsis Before Cystoscopy on Urinary Infections in Laparoscopic Hysterectomy
NCT072324461 location
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
NCT061615061 location
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
NCT0482917510 locations
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
NCT048293574 locations
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
NCT064802277 locations